Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAIL
1401
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $10.7M | 0.01% |
+454,500
| New | +$9.94M |
|
|
FONR
1402
DELISTED
Fonar
FONR
| $10.7M | 0.01% |
544,716
+13,064
| +2% | +$262K |
|
|
LUNA
1403
DELISTED
Luna Innovations Incorporated
LUNA
| $10.7M | 0.01% |
1,471,207
-41,300
| -3% | -$272K |
|
|
AEGN
1404
DELISTED
Aegion Corp
AEGN
| $10.7M | 0.01% |
478,900
+15,400
| +3% | +$333K |
|
|
LGF.B
1405
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $10.7M | 0.01% |
1,077,493
+469,000
| +77% | +$4.05M |
|
|
IMMU
1406
DELISTED
Immunomedics Inc
IMMU
| $10.7M | 0.01% |
+505,302
| New | +$8.91M |
|
1407
Columbus McKinnon
CMCO
$596M
| $10.6M | 0.01% |
266,000
+25,700
| +11% | +$994K |
|
1408
Adobe
ADBE
$98.5B
| $10.6M | 0.01% |
32,233
-21,800
| -40% | -$6.41M |
|
1409
Zurn Elkay Water Solutions
ZWS
$8.31B
| $10.6M | 0.01% |
674,270
-50,032
| -7% | -$720K |
|
|
BRFS
1410
DELISTED
BRF SA
BRFS
| $10.6M | 0.01% |
1,216,453
+646,893
| +114% | +$5.58M |
|
1411
NXP Semiconductors
NXPI
$61.8B
| $10.6M | 0.01% |
+83,087
| New | +$9.64M |
|
1412
Federal Signal
FSS
$7.6B
| $10.6M | 0.01% |
327,300
+117,200
| +56% | +$3.82M |
|
1413
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
| $10.5M | 0.01% |
167,400
-60,600
| -27% | -$3.73M |
|
1414
AtriCure
ATRC
$2.04B
| $10.5M | 0.01% |
323,200
+115,700
| +56% | +$3.29M |
|
1415
AngioDynamics
ANGO
$610M
| $10.5M | 0.01% |
655,214
+149,268
| +30% | +$2.28M |
|
1416
Graham Corp
GHM
$1.1B
| $10.5M | 0.01% |
479,396
+9,417
| +2% | +$203K |
|
1417
Chord Energy
CHRD
$7.78B
| $10.5M | 0.01% |
+3,214,631
| New | +$9.2M |
|
|
MTSC
1418
DELISTED
MTS Systems Corp
MTSC
| $10.5M | 0.01% |
217,900
-23,318
| -10% | -$1.24M |
|
1419
The Bancorp
TBBK
$2.7B
| $10.4M | 0.01% |
805,672
-1,628
| -0.2% | -$18.3K |
|
1420
Gorman-Rupp
GRC
$2.13B
| $10.4M | 0.01% |
278,115
+44,100
| +19% | +$1.61M |
|
|
IBKC
1421
DELISTED
IBERIABANK Corp
IBKC
| $10.4M | 0.01% |
138,948
+21,500
| +18% | +$1.6M |
|
1422
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $10.4M | 0.01% |
97,255
+68,012
| +233% | +$7.25M |
|
1423
Glaukos
GKOS
$9.94B
| $10.4M | 0.01% |
190,292
-73,808
| -28% | -$4.49M |
|
|
HI
1424
DELISTED
Hillenbrand
HI
| $10.3M | 0.01% |
310,520
-263,080
| -46% | -$8.31M |
|
|
FFNW
1425
DELISTED
First Financial Northwest, Inc
FFNW
| $10.3M | 0.01% |
692,200
+17,206
| +3% | +$249K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.